A retrospective cohort study to examine factors affecting live birth following hysteroscopic treatment of intrauterine adhesions
Yuting Zhao,Xiaowu Huang,Rui Huang,Ruonan Xu,Enlan Xia,Tin Chiu Li
DOI: https://doi.org/10.1016/j.fertnstert.2024.01.022
IF: 6.7
2024-01-22
Fertility and Sterility
Abstract:Structured abstract Objective To evaluate independent factors that affect the chance of live birth following hysteroscopic adhesiolysis in patients with intrauterine adhesions (IUAs). Design Retrospective cohort study Setting Hysteroscopic center of Fuxing Hospital in Beijing, China. Patient(s) Patients diagnosed with Asherman syndrome between June, 2020, and February, 2022. Intervention(s) Hysteroscopic adhesiolysis followed by second look hysteroscopy to assess outcome and follow-up for a year. Main Outcome Measure(s) Live birth rate without the use of assisted reproductive technologies at 12 months follow-up. Result (s): Of the 544 women included in the cohort, the pregnancy rate at the end of one year follow-up was 47.6% (95%CI 45.5%-49.7%) and the live birth rate was 41.0% (95%CI 38.9%-43.1%). Stepwise multiple logistic regression analysis identified 3 independent predictors of live birth in decreasing order of significance: increase in menstrual flow after surgery (OR 3.69, 95%CI 1.77–8.21), postoperative endometrial thickness in the mid-luteal phase (OR 1.53, 95%CI 1.31–1.80), and the severity of recurred adhesion at second-look hysteroscopy (OR 0.62, 95%CI 0.50–0.76). Among subjects with good independent prognostic factors, namely, increased menstrual flow after surgery, postoperative endometrial thickness in the mid luteal phase greater than 6mm, no or minimal recurrence of adhesions at second-look hysteroscopy, the live birth rate was 69.0% (95%CI 65.4%-72.6%). On the other hand, in women (n=26) without any of the three good prognostic factors, none had a successful live birth (0%). Conclusion (s): Overall, the live birth rate following treatment of Asherman syndrome was 41.0%. The prognosis is dependent on three outcome measures following surgery, namely, improvement in menstrual flow, post-operative endometrial thickness and minimal degree of recurrent adhesions at second-look hysteroscopy.
obstetrics & gynecology,reproductive biology